Envista (NYSE:NVST - Get Free Report) had its price target increased by stock analysts at Evercore ISI from $19.00 to $23.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an "outperform" rating on the stock. Evercore ISI's price target suggests a potential upside of 13.92% from the stock's current price.
NVST has been the subject of a number of other research reports. Piper Sandler lowered their price objective on Envista from $18.00 to $17.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Bank of America lowered their price objective on Envista from $26.00 to $23.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. Morgan Stanley set a $16.00 price objective on Envista in a research note on Tuesday, April 15th. Robert W. Baird upgraded Envista from a "neutral" rating to an "outperform" rating and raised their price objective for the company from $21.00 to $23.00 in a research note on Tuesday, May 27th. Finally, Baird R W upgraded Envista from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, May 27th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $20.23.
View Our Latest Analysis on Envista
Envista Trading Down 2.6%
NYSE NVST traded down $0.53 during trading hours on Wednesday, hitting $20.19. 1,852,889 shares of the company's stock were exchanged, compared to its average volume of 2,476,945. The business's 50 day moving average is $18.65 and its 200-day moving average is $18.52. Envista has a 12-month low of $14.22 and a 12-month high of $23.00. The firm has a market capitalization of $3.42 billion, a P/E ratio of -3.09, a price-to-earnings-growth ratio of 1.32 and a beta of 1.00. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.82 and a current ratio of 2.12.
Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $0.24 EPS for the quarter, topping the consensus estimate of $0.20 by $0.04. The company had revenue of $616.90 million during the quarter, compared to analyst estimates of $608.17 million. Envista had a positive return on equity of 4.07% and a negative net margin of 44.90%. The firm's revenue was down 1.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.26 earnings per share. As a group, analysts anticipate that Envista will post 1 EPS for the current fiscal year.
Institutional Investors Weigh In On Envista
Large investors have recently bought and sold shares of the business. Ariel Investments LLC lifted its stake in shares of Envista by 0.7% in the 1st quarter. Ariel Investments LLC now owns 12,144,745 shares of the company's stock valued at $209,618,000 after purchasing an additional 85,121 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Envista by 24.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 8,387,297 shares of the company's stock valued at $144,760,000 after purchasing an additional 1,625,206 shares during the period. Franklin Resources Inc. lifted its stake in shares of Envista by 72.6% in the 4th quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company's stock valued at $132,223,000 after purchasing an additional 2,882,844 shares during the period. Gates Capital Management Inc. lifted its stake in shares of Envista by 10.0% in the 1st quarter. Gates Capital Management Inc. now owns 5,163,745 shares of the company's stock valued at $89,126,000 after purchasing an additional 469,597 shares during the period. Finally, Clarkston Capital Partners LLC raised its stake in Envista by 9.3% during the 1st quarter. Clarkston Capital Partners LLC now owns 4,686,747 shares of the company's stock worth $80,893,000 after buying an additional 398,672 shares during the period.
About Envista
(
Get Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Articles

Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.